BioMarin Pharmaceutical Inc.
(BMRN - NASDAQ)
53,94 USD
📋 Profilo Aziendale

BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions.

|